BIOINFRA Life Science

BIOINFRA Life Science’s innovative research continues forthe perfect prevention of cancer and disease.

We continue research and development for global technologies thatopen a new paradigm in healthcare.

 

BIOINFRA Life Science’s research continues today fora future where the health and happiness ofhumanity become a reality.

  • Multi-Biomarker Blood Test

    We are continuously developing technologies that analyze a number of markers within the blood to calculate the risks to different types of cancers by analyzing our own big data statistical analysis algorithm.
  • Diagnosis Kit Development

    Currently in development of a simple and accurate diagnosis kit which can analyze disease risks after blood extractions, without expensive medical equipment in hospitals and clinics.
  • Biomarker Discovery

    Constantly excavating new peptide biomarkers that meaningfully contribute to cancer risk diagnosis, with an aim toward accurate and efficient multi-biomarker testing.
  • Peptide Chip Development

    Currently proceeding with the development of peptide chips that apply the unique characteristics of peptide such as peptide chip diagnostic analysis, quantitative analysis, interaction analysis, and mass spectrometry.
  • Targeted Cancer Therapy

    We are currently developing a targeted cancer therapy system for effective cancer therapy.
  • Targeted Drug Delivery Technology

    We are developing microbubbles and ultrasound for an enhanced delivery of anticancer drugs and gene therapeutic drugs.
"The doctor of the future will give no medicine,but will educate his patients in the care of the human frame, in diet,and in the cause and prevention of disease."

Thomas A. Edison, 1847-1931